PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGene therapy injected in one eye improves vision in both

BioNews

Gene therapy injected in one eye improves vision in both

Published 11 December 2020 posted in News and appears in BioNews 1076

Author

Julianna Photopoulos

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Vision improves in both eyes when gene therapy is administered to only one eye, an international team of researchers has found whilst treating a rare form of blindness...

Vision improves in both eyes when gene therapy is administered to only one eye, an international team of researchers has found, whilst treating a rare form of blindness.

The team injected a harmless virus containing the gene into the back of one eye of 37 patients who had vision loss for six to 12 months from a condition called Leber hereditary optic neuropathy (LHON). Nearly two years after treatment, 29 of them had at least some vision improvements in both eyes. Of these, 25 had clinically relevant improvement in their treated eye.

'We expected vision to improve in the eyes treated with the gene therapy vector only. Rather unexpectedly, both eyes improved for 78 percent of patients in the trial following the same trajectory over two years of follow-up,' said lead author Dr Patrick Yu-Wai-Man at the University of Cambridge.

LHON usually affects young men and leads to vision loss. Although there is a lack of effective therapies, it is known to be caused by a mutation in one of the genes inside mitochondria that affects cells of the retina. These cells take up the gene when it is injected into the eye and can then start producing the protein needed to preserve the rest of their retina.

To further investigate why vision improved in both eyes, the team used the gene therapy in three macaque monkeys. After three months, they examined their visual system, which is similar to that of humans, and found all three monkeys had the virus in both their eyes. The virus was also seen in their optic nerves, suggesting that the virus used the optic nerves to travel between the treated and untreated eye.

According to the New Scientist, the discovery has safety implications and raises questions on its effectiveness. Normally, in similar clinical trials, vision would be compared between the treated and untreated eye – something that wasn't possible in this case. Dr Yu-Wai-Man said that future trials may need to compare people given the gene therapy to others who receive a placebo.

Professor Michel Michaelides, an ophthalmologist at University College London and Moorfields Eye Hospital, called the news 'fascinating', telling New Scientist: 'It's an important finding that should be taken into account when designing studies'.

Nevertheless, senior investigator Professor José-Alain Sahel from the University of Pittsburgh is feeling hopeful for these patients who have limited treatment options. He said: 'These patients rapidly lose vision in the course of a few weeks to a couple of months. Our study provides a big hope for treating this blinding disease in young adults.'

The study was published in the journal Science Translational Medicine.

Sources and References

  • 09/12/2020
    Science Translational Medicine
    Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy
  • 10/12/2020
    University of Cambridge
    Gene therapy injection in one eye surprises scientists by improving vision in both
  • 09/12/2020
    New Scientist
    Gene therapy injected in one eye can travel to the other eye

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
18 March 2021 • 2 minutes read

Gene therapy benefits seen decades after treatment

by Beatrice Costa

Healthy immune cells are still forming 18 years after blood stem cell transplantation in patients with faulty immune systems, research has found...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
8 March 2021 • 3 minutes read

Animation Review: Gene Therapy Explained — Changing our body's recipe to treat disease

by Ailsa Stevens

The pandemic has created huge demand for high quality home learning materials. One such resource is Great Ormond Street Hospital's new short film on gene therapy...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 March 2020 • 2 minutes read

CRISPR genome editing used directly in patient's eye

by Charlotte Spicer

A team of researchers in the US has become the first to use the genome-editing tool CRISPR directly on a person's body...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 February 2020 • 2 minutes read

Retinal gene therapy trial shows positive result

by Dr Hannah Somers

A clinical trial using gene therapy for treating a common cause of genetic blindness published positive results in Nature Medicine...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 February 2020 • 2 minutes read

Gene therapy for blindness begins on the NHS

by Dr Jay Stone

The NHS has started to offer people with an inherited retinal disorder, known as Leber's Congenital Amaurosis (LCA) a revolutionary new gene therapy, which can restore their eyesight...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Acoustic waves used to select high-quality sperm in IVF

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856